Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow TREVENA INC

Get SEC filing alerts via email and in your feed for TREVENA INC

TRVN

TREVENA INC

About TREVENA INC

Trevena, Inc. is a biopharmaceutical company focused on developing and commercializing novel medicines for central nervous system disorders. Its key product, OLINVYK, is an FDA-approved intravenous opioid for acute pain management. The company also develops proprietary pipeline candidates targeting pain, epilepsy, and inflammatory diseases, leveraging innovative mechanisms and patent protections to address significant unmet medical needs in CNS therapeutics.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from TREVENA INC

1
1
TREVENA INC Trevena Reports Significant Financial Changes, Net Loss Improvement, and Strategic Adjustments in 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments